These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 26134001

  • 1. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
    da Costa PM, da Costa MP, Carvalho AA, Cavalcanti SM, de Oliveira Cardoso MV, de Oliveira Filho GB, de Araújo Viana D, Fechine-Jamacaru FV, Leite AC, de Moraes MO, Pessoa C, Ferreira PM.
    Chem Biol Interact; 2015 Sep 05; 239():174-83. PubMed ID: 26134001
    [Abstract] [Full Text] [Related]

  • 2. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS, Kit-Lam C, Majid AM, Al-Suede FS, Mohammed Saghir SA, Abdullah WZ, Ahamed MB, Yusoff NM.
    Microvasc Res; 2013 Nov 05; 90():30-9. PubMed ID: 23899415
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The antiangiogenic properties of sulfated β-cyclodextrins in anticancer formulations incorporating 5-fluorouracil.
    Watson CA, Vine KL, Locke JM, Bezos A, Parish CR, Ranson M.
    Anticancer Drugs; 2013 Aug 05; 24(7):704-14. PubMed ID: 23695012
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT, Marzaro G, Urbani L, Zanusso I, Di Liddo R, Castagliuolo I, Brun P, Tonus F, Ferrarese A, Guiotto A, Chilin A.
    Eur J Med Chem; 2013 Sep 05; 67():373-83. PubMed ID: 23900004
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K, Bao Y, Liu F, Xiao C, Li K, Zhang C, Huang R, Lin J, Zhang J, Jin Y.
    Eur J Med Chem; 2019 Oct 01; 179():805-827. PubMed ID: 31295714
    [Abstract] [Full Text] [Related]

  • 11. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L, Du J.
    Oncol Rep; 2013 Mar 01; 29(3):1080-6. PubMed ID: 23254951
    [Abstract] [Full Text] [Related]

  • 12. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A, Aigner A, Bakowsky U.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt A):711-5. PubMed ID: 23891770
    [Abstract] [Full Text] [Related]

  • 13. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W, Jin K, Lan H, Han N, Cao F, Teng L.
    Hepatogastroenterology; 2012 Nov 01; 59(120):2543-7. PubMed ID: 22534543
    [Abstract] [Full Text] [Related]

  • 14. Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
    Beedie SL, Peer CJ, Pisle S, Gardner ER, Mahony C, Barnett S, Ambrozak A, Gütschow M, Chau CH, Vargesson N, Figg WD.
    Mol Cancer Ther; 2015 Oct 01; 14(10):2228-37. PubMed ID: 26269604
    [Abstract] [Full Text] [Related]

  • 15. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J, Chen Y, Wei L, Hong Z, Sferra TJ, Peng J.
    Int J Oncol; 2013 Nov 01; 43(5):1666-74. PubMed ID: 24042330
    [Abstract] [Full Text] [Related]

  • 16. Preparation, antiangiogenic and antitumoral activities of the chemically sulfated glucan from Phellinus ribis.
    Liu Y, Liu Y, Jiang H, Xu L, Cheng Y, Wang PG, Wang F.
    Carbohydr Polym; 2014 Jun 15; 106():42-8. PubMed ID: 24721049
    [Abstract] [Full Text] [Related]

  • 17. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M, Tak J, Chung WY, Park KK.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1227-30. PubMed ID: 16380253
    [Abstract] [Full Text] [Related]

  • 18. CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity.
    Vu HN, Miller WJ, O'Connor SA, He M, Schafer PH, Payvandi F, Muller GW, Stirling DI, Libutti SK.
    J Surg Res; 2010 Nov 01; 164(1):116-25. PubMed ID: 19726061
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
    Kumar A, D'Souza SS, Nagaraj SR, Gaonkar SL, Salimath BP, Rai KM.
    Cancer Chemother Pharmacol; 2009 Nov 01; 64(6):1221-33. PubMed ID: 19370348
    [Abstract] [Full Text] [Related]

  • 20. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
    Thapa D, Lee JS, Heo SW, Lee YR, Kang KW, Kwak MK, Choi HG, Kim JA.
    Eur J Pharmacol; 2011 Jan 10; 650(1):64-71. PubMed ID: 20950604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.